ImmuCell Corporation (ICCC) stock news · rev $27.6M
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
This ICCC news page leads with what ImmuCell Corporation filed — not a scraped headline mill.
No cached 8-K sentence for ICCC yet. We will not pad this page with generic market recap.
Latest reported ICCC revenue for 2025-12-31 was $27.6M. Net income was -$1.0M. Revenue was up 58.2% from 2023-12-31 to 2025-12-31. ICCC currently screens at market cap $58.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ICCC stock page; for the tape open the quote page.
ICCC stock news FAQ
What are ICCC's latest revenue and net income?
Latest cached ImmuCell Corporation (ICCC) revenue for Dec 31, 2025 was $27.6M. Net income was -$1.0M. Statements: https://lician.com/financials/iccc
How did ICCC revenue change from the prior cached period?
Cached ImmuCell Corporation (ICCC) revenue was up 58.2% from $17.5M (Dec 31, 2023) to $27.6M (Dec 31, 2025). Statements: https://lician.com/financials/iccc
What is ICCC's market cap?
ImmuCell Corporation (ICCC) market cap is $58.9M on the latest cached fundamentals snapshot.
What kind of company is ICCC?
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Where is ICCC stock news listed?
Cached stock news for ImmuCell Corporation (ICCC) is listed at https://lician.com/news/iccc. Filings: https://lician.com/sec/iccc
Not investment advice.